Annual report pursuant to Section 13 and 15(d)

Summary of Significant Policies (Tables)

v3.20.1
Summary of Significant Policies (Tables)
12 Months Ended
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company had the following common stock equivalents at December 31, 2018 and 2017.

 

    2018     2017  
Convertible preferred stock, Series A     2,395,830       1,146,797  
Convertible preferred stock, Series A-1     767,040       727,703  
Convertible preferred stock, Series G           178,000  
Convertible notes     21,303,158       1,847,057  
Common stock warrants     287,484       330,856  
Options     19,010       1,318  
Total potentially dilutive shares     24,772,522       4,231,731